Outer membrane vesicles as platform vaccine technology

por van der Pol, Leo, Stork, Michiel, van der Ley, Peter
Publicado 2015

Automated cell counting for Trypan blue-stained cell cultures using machine learning

por Kuijpers, Louis, van Veen, Edo, van der Pol, Leo A., Dekker, Nynke H.
Publicado 2023

Online automatic tuning and control for fed-batch cultivation

por Soons, Zita I. T. A., van Straten, Gerrit, van der Pol, Leo A., van Boxtel, Anton J. B.
Publicado 2007

Improved poliovirus d-antigen yields by application of different Vero cell cultivation methods

por Thomassen, Yvonne E., Rubingh, Olaf, Wijffels, René H., van der Pol, Leo A., Bakker, Wilfried A.M.
Publicado 2014

Development of an animal component free production process for Sabin inactivated polio vaccine

por Suarez-Zuluaga, Diego A., van der Pol, Leo A., van 't Oever, Aart G., Bakker, Wilfried A.M., Thomassen, Yvonne E.
Publicado 2022

Modeling Neisseria meningitidis metabolism: from genome to metabolic fluxes

por Baart, Gino JE, Zomer, Bert, de Haan, Alex, van der Pol, Leo A, Beuvery, E Coen, Tramper, Johannes, Martens, Dirk E
Publicado 2007

Hematopoietic Cancer Cell Lines Can Support Replication of Sabin Poliovirus Type 1

por Oosterhoff, Dinja, van de Weerd, Gerard, van Eikenhorst, Gerco, de Gruijl, Tanja D., van der Pol, Leo A., Bakker, Wilfried A. M.
Publicado 2015

Next Generation Inactivated Polio Vaccine Manufacturing to Support Post Polio-Eradication Biosafety Goals

por Thomassen, Yvonne E., van ’t Oever, Aart G., van Oijen, Monique G. C. T., Wijffels, René H., van der Pol, Leo A., Bakker, Wilfried A. M.
Publicado 2013

Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes

por Kon, Theone C., Onu, Adrian, Berbecila, Laurentiu, Lupulescu, Emilia, Ghiorgisor, Alina, Kersten, Gideon F., Cui, Yi-Qing, Amorij, Jean-Pierre, Van der Pol, Leo
Publicado 2016

Cysteine Depletion Causes Oxidative Stress and Triggers Outer Membrane Vesicle Release by Neisseria meningitidis; Implications for Vaccine Development

por van de Waterbeemd, Bas, Zomer, Gijsbert, van den IJssel, Jan, van Keulen, Lonneke, Eppink, Michel H., van der Ley, Peter, van der Pol, Leo A.
Publicado 2013

Improved Production Process for Native Outer Membrane Vesicle Vaccine against Neisseria meningitidis

por van de Waterbeemd, Bas, Zomer, Gijsbert, Kaaijk, Patricia, Ruiterkamp, Nicole, Wijffels, René H., van den Dobbelsteen, Germie P. J. M., van der Pol, Leo A.
Publicado 2013

The TB vaccine development pathway – An innovative approach to accelerating global TB vaccine development

por Roordink, Danielle, Williams, Ann, Fritzell, Bernard, Laddy, Dominick J., Gerdil, Emmanuelle, Graffin, Anne Marie, Tait, Dereck, van der Pol, Leo, van den Brink, Ilona, Holleman, Marit, Thole, Jelle, Voss, Gerald, Lempicki, Maria, Thiry, Georges
Publicado 2021